We are live on ! Find out more
SCM

Stonebridge Capital Management Portfolio holdings

AUM $220M
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$281M
AUM Growth
+$15.4M
Cap. Flow
-$10.5M
Cap. Flow %
-3.73%
Top 10 Hldgs %
36.05%
Holding
145
New
5
Increased
21
Reduced
65
Closed
6

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.62M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$1.36M
3
CVX icon
Chevron
CVX
+$1.12M
4
SLB icon
SLB Ltd
SLB
+$623K
5
WSM icon
Williams-Sonoma
WSM
+$578K

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 17.32%
3 Industrials 14.22%
4 Energy 11.1%
5 Consumer Staples 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFMS
126
DELISTED
Conformis, Inc. Common Stock
CFMS
$108K 0.04%
1,651
+171
+12% +$13.7K
NRO
127
Neuberger Real Estate Securities Income Fund Inc
NRO
$193M
$53K 0.02%
10,480
GLDD
128
DELISTED
Great Lakes Dredge & Dock
GLDD
$52K 0.02%
10,000
MVIS icon
129
Microvision
MVIS
$83.3M
$51K 0.02%
34,400
+23,700
+221% +$45.6K
EVRC
130
DELISTED
EVERCEL INC
EVRC
$16K 0.01%
10,000
MRIN
131
DELISTED
Marin Software
MRIN
-1,317
Closed -$97K
SRPT icon
132
Sarepta Therapeutics
SRPT
$1.61B
-5,835
Closed -$265K
VTRS icon
133
Viatris
VTRS
$20.9B
-9,000
Closed -$282K
WT icon
134
WisdomTree
WT
$2.83B
-21,265
Closed -$217K
EVHC
135
DELISTED
Envision Healthcare Holdings Inc
EVHC
-30,329
Closed -$1.36M
MOBL
136
DELISTED
MobileIron, Inc.
MOBL
-11,675
Closed -$43K

Similar funds

Stonebridge Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Stonebridge Capital Management held 145 positions worth $281M, up 5.8% from $266M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Stonebridge Capital Management withdrew a net $10.5M in Q4 2017, closing 6 positions and reducing 65 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $1.36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Stonebridge Capital Management opened a new position in Regeneron Pharmaceuticals worth $634K.

  • Stonebridge Capital Management's largest Q4 2017 buy was Regeneron Pharmaceuticals: 1,728 shares worth $634K.
  • Stonebridge Capital Management added most to Gilead Sciences in Q4 2017, an estimated $902K increase.
  • Stonebridge Capital Management's biggest Q4 2017 reduction was Qualcomm, cutting an estimated $1.62M.
  • Stonebridge Capital Management fully exited Envision Healthcare Holdings Inc in Q4 2017, selling an estimated $1.36M.
  • Stonebridge Capital Management's ten largest holdings make up 36% of its $281M portfolio in Q4 2017.
  • Stonebridge Capital Management opened 5 new positions and closed 6 in Q4 2017.
  • Stonebridge Capital Management's portfolio value rose 5.8% quarter-over-quarter to $281M.

Based on Stonebridge Capital Management's 13F filing for Q4 2017, filed 29 Jan 2018.